''Glioblast licensed the compound from Roche’s Genentech.
Who is Glioblast? I’m glad you asked — and goodness, it’s a very small biotech world.
The Sydney company was owned by Viralytics chairman Paul Hopper (Genentech’s former program leader for GDC-0084) and Leslie Chong, now Imugene’s CEO.''
Why would Genentechs former program leader for GDC0084 sell his holding at the first opportunity when his shares came out of escrow ?
https://unauthorised investment advice/health/kazia-wants-to-cure-the-disease-that-delivered-the-trump-presidency/
DYOR
- Forums
- ASX - By Stock
- KZA
- Ann: Change in substantial shareholder interest
Ann: Change in substantial shareholder interest, page-16
-
-
- There are more pages in this discussion • 86 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online